Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Nanomedicine. 2021 Sep 13;39:102459. doi: 10.1016/j.nano.2021.102459

Table 1.

Composition and loading characteristics of PTX-NFGs

Formulation MNP: POx-Dopamine ratio Feeding amount (mg) Loading Efficiency (LE)1 (%) Loading capacity (LC)2 (%)
POx POx-Dopamine PTX MNPs PTX MNPs PTX MNPs
PTX-NFG/A 1:4 8 2 2 0.5 106.9 67.5 17.1 2.7
PTX-NFG/B 1:8 8 2 2 0.24 88.2 68.8 14.4 1.2
PTX-NFG/C 1:40 8 2 2 0.05 95.8 72.3 15.9 0.3
PTX-NFG/D 1:4 0 10 2 2.4 97.9 69.0 13.5 11.9
PTX-NFG/E 1:8 0 10 2 1.2 100.0 71.0 15.1 6.7
PTX-NFG/F 1:40 0 10 2 0.24 102.3 63.7 16.7 1.3
1

LE (wt. %) of either PTX (or MNPs) was calculated as the amount of PTX (or MNP) in final formulation/the feed amount of PTX (or MNP) X100.

2

LC (wt %) for either PTX or MNPs was calculated as the amount of PTX or MNPs in final formulation X100 / the amount of dispersed phase in the formulation.